Background: Long-term data on device-related untoward events in patients receiving defibrillators for resynchronization therapy (CRT-D) are lacking. We quantified the frequency of repeat invasive procedures and the nature of long-term complications in current clinical practice and examined possible predictors of device-related events and their association with long-term patient outcome. Methods and results: We analyzed data from 3253 patients who underwent de novo successful implantation of CRT-D and were followed up for a median of 18 months (25th to 75th percentiles: 9 to 30) in 117 Italian centers. Device-related events were reported in 416 patients, and, specifically, surgical interventions for system revision were described in 390 pati...
Background: Current real-life information from all-comers registries from middle and east Europe abo...
Introduction: Comparison data on management of device-related complications and their impact on pati...
Aim: Ventricular tachycardia (VT)/ventricular fibrillation (VF) occurrence after cardiac resynchroni...
Background: Long-term data on device-related untoward events in patients receiving defibrillators fo...
Background—Long-term data on device-related untoward events in patients receiving defibrillators for...
Aims: The benefit of prolonged implantable cardioverter-defibrillator (ICD)/cardiac resynchronizatio...
AimsThe long-term impact of implantable device-related complications on the patient outcome has not ...
Background: Recently, the Food and Drug Administration issued a recall for the subcutaneous implanta...
Background: Long-term nonfatal outcomes after implantable cardioverter-defibrillator (ICD) placement...
The replacement of implantable cardioverter-defibrillators (ICDs) may give rise to considerable clin...
BackgroundThe transvenous implantable cardioverter‐defibrillator (ICD) lead is the most common sourc...
Background: Implantable cardioverter-defibrillators (ICDs) are widely employed for the prevention of...
Aims Some barriers seem to exist in changing implantable cardioverter defibrillator (ICD) manufactur...
Background: Current real-life information from all-comers registries from middle and east Europe abo...
Introduction: Comparison data on management of device-related complications and their impact on pati...
Aim: Ventricular tachycardia (VT)/ventricular fibrillation (VF) occurrence after cardiac resynchroni...
Background: Long-term data on device-related untoward events in patients receiving defibrillators fo...
Background—Long-term data on device-related untoward events in patients receiving defibrillators for...
Aims: The benefit of prolonged implantable cardioverter-defibrillator (ICD)/cardiac resynchronizatio...
AimsThe long-term impact of implantable device-related complications on the patient outcome has not ...
Background: Recently, the Food and Drug Administration issued a recall for the subcutaneous implanta...
Background: Long-term nonfatal outcomes after implantable cardioverter-defibrillator (ICD) placement...
The replacement of implantable cardioverter-defibrillators (ICDs) may give rise to considerable clin...
BackgroundThe transvenous implantable cardioverter‐defibrillator (ICD) lead is the most common sourc...
Background: Implantable cardioverter-defibrillators (ICDs) are widely employed for the prevention of...
Aims Some barriers seem to exist in changing implantable cardioverter defibrillator (ICD) manufactur...
Background: Current real-life information from all-comers registries from middle and east Europe abo...
Introduction: Comparison data on management of device-related complications and their impact on pati...
Aim: Ventricular tachycardia (VT)/ventricular fibrillation (VF) occurrence after cardiac resynchroni...